Research progress in lncRNA and its action as ceRNA in ovarian function as well as the relevant diseases

Yuling Li1, Jie Chen2, Qianqian Luo1

  • 1Department of Gynecology of Traditional Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing 210023.

Insights

Long non-coding RNAs (lncRNAs) regulate gene expression and ovarian function. These molecules form regulatory networks with microRNAs (miRNAs) and mRNAs, offering potential diagnostic and therapeutic targets for reproductive disorders.

Area of Science:

  • Molecular Biology
  • Reproductive Biology
  • Genetics

Background:

  • Long non-coding RNAs (lncRNAs) are key regulators of gene expression, influencing transcription, post-transcriptional modification, and epigenetic processes.
  • lncRNAs play a crucial role in maintaining normal ovarian physiological function.
  • Dysregulation of lncRNAs is implicated in the development of ovarian reproductive disorders.

Purpose of the Study:

  • To elucidate the role of lncRNAs in ovarian physiology and reproductive disorders.
  • To explore the lncRNA/microRNA (miRNA)/messenger RNA (mRNA) regulatory network in the ovary.
  • To identify lncRNAs as potential diagnostic markers and therapeutic targets for ovarian diseases.

Main Methods:

  • Investigated the regulatory mechanisms of lncRNAs in ovarian gene expression.
  • Analyzed the competitive endogenous RNA (ceRNA) activity of lncRNAs, focusing on their interaction with miRNAs.
  • Examined the lncRNA/miRNA/mRNA regulatory network's involvement in ovarian function and disorders.

Main Results:

  • lncRNAs significantly impact ovarian physiological functions through various regulatory pathways.
  • The lncRNA/miRNA/mRNA network is critical for maintaining ovarian homeostasis.
  • Alterations in this network are associated with the pathogenesis of ovarian reproductive disorders.

Conclusions:

  • lncRNAs are integral to ovarian function and reproductive health.
  • The lncRNA/miRNA/mRNA regulatory network represents a significant area for understanding ovarian disorders.
  • lncRNAs show promise as novel diagnostic indices and therapeutic targets for treating reproductive disorders.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.2K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.0K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K